The 2 Minute Medicine® Podcast

We begin with a discussion about our article of the week from the Lancet and is entitled “Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data“. In the second half of the episode we have a conversation about the rise in counterfeit Botox use, the cognitive benefits of playing chess, pros and cons of melatonin supplements and the recent increase in reported Measles cases. 

We begin with a discussion about our article of the week from JAMA, entitled “Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes”  In the second half of the episode, we begin with talking about a pioneering immunotherapy approach for brain cancer. Then we discuss the advantages of access to over-the-counter birth control. After that, we take a look at abortion ban rulings issued by the Florida Supreme Court. Finally, we go over cardiac pacemakers and how they have changed over time. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week entitled “Electronic nicotine delivery systems for smoking cessation. In the second half of the episode, we discuss Kate Middleton’s recent cancer diagnosis and have a conversation about cancer trends that have recently made the news. Next, we follow with a discussion about the first person to undergo kidney transplantation from a genetically altered pig, take a closer look at the solar eclipse and its impact on eye health, and conclude with a conversation about lab-grown meat and what the research has shown so far.

In this episode, we begin with a discussion about our article of the week entitled “An umbrella review and meta-analysis of meta-analyses of the impact of Ramadan fasting on the metabolic syndrome components“. Next, we talk about a new cure strategy for HIV. Then we discuss issues revolving around psychotropic polypharmacy in youth. After that, we take a look at a new method to improve IVF treatments. Finally, we go over the recent cyberattack at UnitedHealth’s Change Healthcare and its consequences.

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.” Then we discuss the challenges and recovery after having brain aneurysm and talk about the first disease modifying FDA approved drug for Alzheimer’s disease. After that, we take a look at liver transplant in children. Finally, we go over psoriasis and briefly go over risk factors and treatments.

We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Apixaban for stroke prevention in subclinical atrial fibrillation”. In the second half of the episode, we begin with a discussion about stroke in young patients with Lupus. Then we discuss how Starting January 29th British Columbia began providing Canada’s first-at-home self HPV screening test kits for cervical cancer. Last but not least, we take a closer look at acne, current treatments, and a possible vaccine that has shown promise in mouse models, and conclude with a conversation about opioids.

We begin this episode by discussing our article of the week which comes from the BMC Nutrition Journal and is entitled “Clusters of carbohydrate-rich foods and associations with type 2 diabetes incidence: a prospective cohort study.” We begin with a discussion about blood donation, and the decline we are seeing in blood donors. Then we take a closer look at lead poisoning in the context of a recent recall of contaminated cinnamon applesauce products. After that, we investigate multiple sclerosis and how it can affect one’s life. Finally, we discuss the cold winter temperatures, the risks of the cold, and how we can stay safe this winter.

In this episode, we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Teplizumab and beta-cell function in newly diagnosed type 1 diabetes.” Then we take a closer look at allergies and new treatments on the horizon for food allergies. Next, a discussion about lung cancer, following the recent passing of Andre Braugher. Last but not least, we discuss New Year’s resolutions along with evidence-based ways to make them last and explore the rise in cases of counterfeit Ozempic use, and how this has affected the world. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the Annals of Internal Medicine and is entitled “Cardiovascular health of middle-aged US adults by income level, 1999 to March 2020: A serial cross-sectional study.” In the second half, we begin by discussing an increasingly popular procedure used in infants who are struggling with breastfeeding. Then we delve into the new findings that a hormone, GDF15, is linked to morning sickness. After this, we discuss ketamine, the drug that was implicated in the tragic passing of 'Friends' star Matthew Perry. Finally, we end with a conversation about the ongoing generic drug shortages occurring across the country.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of  gonorrhea, Zoliflodacin. Last but not least, we discuss why ⁠March of Dimes⁠, a maternal and infant health organization, issued ⁠a D+ to the USA⁠ for the 2nd year in a row for its relatively high rate of preterm births.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠⁠https://bit.ly/2zZnJt9⁠

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021”.  We then dive deeper into a discussion about seasonal affective disorder, its treatment, and its impact on the population. Then we take a closer look at the Movember movement and how it relates to men’s health. After that, we discuss the recent surge in syphilis cases and what can be done about it. Last, but not least, we have a conversation about substance use disorders in the wake of Matthew Perry’s passing. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study”. In the second half of our episode, we start off by discussing the issue of performance-enhancing drugs in sports following the news of a  banned substance scandal in the men's marathon. Next, we will dive into the NHL's Pride Tape ban and their decision to reverse the ban following public push-back. Finally, we end with conversations about the bedbug outbreak in Paris, and new studies highlighting the value of wearable technology in diagnosing and monitoring Parkinson's disease. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled ““Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.” In the second half of our episode, we begin by taking a closer look at the public heath crisis in Gaza. Next, we discuss a recently published study in JAMA, and examine the possible link between ADHD and Dementia. Last but not least, a short discussion about the significance of October being National Pregnancy and Infant Loss Awareness Month. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH”. In the second half of our episode, we begin by exploring the recently announced price drop for a popular tuberculosis test. Then we discuss Sufjan Stevens' ongoing battle with the rare autoimmune condition, Guillain-Barre Syndrome. Finally, we end with a conversation about newly developed tests to identify medical abortions and the ongoing American Red Cross blood supply shortage. 

We begin this episode by discussing our article of the week from JAMA Network Open, entitled “Women’s Adherence to Healthy Dietary Patterns and Outcomes of Infertility Treatment”. In the second half of our episode, we begin with a discussion about Shohei Ohtani, the superstar baseball player fighting against a torn ligament. Next, we look at blue light glasses, an increasingly popular way to combat eye strain in the digital world. After that, we discuss sciatica, and how this disease affects the lives of many, including some famous names. Finally, we discuss the long-term and short-term impacts of concussion and CTE.

We begin this episode by discussing our article of the week from the Lancet “Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA”. In the second half of our episode, we begin with a discussion of Wegovy and the latest data on its human use. Next, we discuss congenital heart disease in sports. Following that, we examine the latest developments with the COVID-19 virus, and last but not least, we examine the recent news about long-lasting chemicals found in paper straws, and their impact on human health.

We begin this episode by discussing our article of the week from from the New England Journal of Medicine, entitled “Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.” In the second half, we have a conversation about Alzheimer's disease and how a drug called Donanemab has shown a 29% slower rate of decline and cognitive function. Next, we look at complications of bariatric surgery, the medical effects of heat exhaustion and what we can do to prevent it, and conclude with a conversation about energy drinks and it's lesser known side effects.

We begin this episode by discussing our article of the week from JAMA and is entitled, “Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021. In the second half of our episode, we begin by discussing the FIFA Women's World Cup and some of the strides taken to protect and support female athletes. Then we discuss National Immunization Awareness Month and some health tips for heading back-to-school. Finally, we conclude with a discussion on Overdose Awareness Day and the importance of naloxone in preventing deaths due to overdose.

We begin this episode by discussing our article of the week from BMC medicine, “Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial”. In the second half of our episode, we begin with a discussion about a blood test that was recently approved by the federal drug administration that can detect those at a greater risk for pre-eclampsia. Then we discuss the American Medical Association's new policy regarding the use of BMI in medical practice. Finally, we end with a conversation about Madonna's recent sepsis scare, as well as some of the injuries seen in the latest edition of the Tour de France.